Skip to content

Circulatory Levels of Irisin in Response to Chronic Resistance Training

Circulatory Levels of Irisin in Response to Chronic Resistance Training

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02475473
Enrollment
28
Registered
2015-06-18
Start date
2015-02-28
Completion date
Unknown
Last updated
2015-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Volunteers

Brief summary

Study the responses of circulatory irisin to chronic high-intensity resistance training

Detailed description

Objective: The purpose of this study is to study the circulating levels of irisin in response to chronic high-intensity resistance training in a group of healthy young adults. Sample: The sample will be comprised 44 of adult men and women unpaid volunteers between the ages of 18 and 30. Pre-screening assessments: Informed consent, PAR-Q, Medical History and Exercise History will be used to determine health status and prior exercise experience. Menstrual cycle log will be required for female participants. Pre-Intervention assessments: * Anthropometric measurements and Body Composition: Height, triceps, thigh and calf skinfolds, biceps, thigh, hip, waist, and calf circumferences will be measured. Dual-energy x-ray absorptiometry (DEXA) will be performed to obtain body composition. * Cardiopulmonary and Strength Fitness Testing. Cardiopulmonary fitness will be determined via maximum oxygen uptake testing. One maximum repetition (1-RM) will be used to assess the muscular fitness. * Spontaneous Physical Activity: Daily activity level for 7 days will be collected. * Familiarization. Participant will be instructed on the muscle conditioning techniques used for strength training so that the techniques can be mastered. The rate of perceived exertion (RPE) scale will also be used for familiarization during these sessions. Intervention: The intervention will last 3 weeks with a frequency of 3 training session per week. We will collect blood samples levels at session 1 (at the beginning of week 1), session 3 (at the end of week 1), at session 6 (at the end of week 2) and session 9 (at the end of week 3). Blood draws will occur at the beginning of each session evaluated (pre-session), at the 45 min mark during each session and immediately after each session (post-session). The sessions will consist on a circuit training of 3 sets of 7 exercises focused on major muscle groups. Ten repetitions on each circuit at 70% of the maximum capacity will be performed. During the intervention: \- Blood-related variables. Baseline glucose, lactate and hematocrit will be obtained from all participants prior to intervention. Lactate and Hematocrit will be obtained pre-intervention and post-intervention, and within 1 min post workout at sessions 1, 3, 6 and 9. Irisin will be obtained from blood samples at baseline, during and after training sessions 1, 3, 6 and 9. Irisin will be measured via a commercial enzyme-linked immunosorbent assay. \- Dietary Controls. Each participant will complete the Food Preference Questionnaire. In addition, the Automated Self-Administered 24-hour Recall (ASA24) will be collected for the days prior to sessions 1, 3, 6 and 9. Post-Intervention assessments: * Anthropometric measurements and Body Composition: Height, triceps, thigh and calf skinfolds, biceps, thigh, hip, waist, and calf circumferences will be measured. Dual-energy x-ray absorptiometry (DEXA) will be performed to obtain body composition. * Caridorespiratory capacity determined via maximum oxygen uptake testing. One maximum repetition (1-RM) will be used to assess the muscular fitness. * Spontaneous Physical Activity: Daily activity level for 7 days will be collected.

Interventions

OTHERExercise Training

Chronic High-Intensity Resistance Training

Sponsors

Texas Tech University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 30 Years
Healthy volunteers
Yes

Exclusion criteria

* Known health problems such as cardiovascular, pulmonary or metabolic disease will be excluded. * Pregnant females. * Any adults found taking medications that affect endocrine or cardiovascular function will also be excluded from the study. * Individuals found to be less than 110 pounds. * Participants that exercise more than three times per week or strength train more than twice per week. * Individuals that have poor venous access or have expressed a fear of needles or having blood taken will also be excluded. * Cigarette smoking (current or those who quit within the previous 6 months * Hypertension * Overweight and obese * Pre-diabetics

Design outcomes

Primary

MeasureTime frameDescription
Change in Serum irisin levelsBaseline and 3 weeks
Blood Lactate levels3 weeksIntensity of exercise on sessions 1, 3, 6 and 9
Changes in physical fitness levels as meassured by 1RM (repetition maximum) and Cardio-respiratory maximal testingBaseline and 3 weeks
Changes in Body composition assessment: DEXA and anthropometryBaseline and 3 weeks
Changes in Blood glucose levelsBaseline and 3 weeks
Changes in Hematocrit concentrationBaseline and 3 weeks
Diet assessment: 24 hour recall and Food Preference Questionnaire3 weeks
Physical Activity assessment: accelerometry3 weeks

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026